Skip to Content

Riquent Approval Status

FDA Approved: No
Brand name: Riquent
Generic name: abetimus sodium
Company: La Jolla Pharmaceutical Company
Treatment for: Systemic Lupus Erythematosus

Development Status and FDA Approval Process for Riquent

DateArticle
Mar 14, 2005La Jolla Pharmaceutical Announces Outcome of Recent FDA Discussions
Oct 14, 2004La Jolla Pharmaceutical Company Receives Letter From FDA About Riquent
Feb 17, 2004La Jolla Pharmaceutical’s New Drug Application for Lupus Drug Candidate Riquent Accepted for Review by FDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide